domingo, 14 de septiembre de 2014

Turning the Tide Against Cancer

Turning the Tide Against Cancer

Turning the Tide
 Against Cancer Through Sustained Medical Innovation

Turning the Tide Against Cancer
2014 National Conference
Thursday, October 9, 2014
Washington, D.C.
One Month Left to Register!

The Turning the Tide Against Cancer 2014 National Conference is one month 

away! Register now and join key stakeholders in the cancer community on 
October 9th in Washington, D.C., to take part in panel discussions and spotlight 
series that will explore potential policy solutions that support patient-centered, 
high-value cancer research and care, while addressing challenges with rising 
healthcare costs.

View the full agenda of scheduled spotlight speakers and panelists.

Special Guest Speaker:
Suleika JaouadThe New York Times Emmy® Award Winning Columnist, 
"Life, Interrupted," and Cancer Survivor

Speakers and Panelists Include:
Amy Abernethy, M.D., Ph.D., Professor of Medicine, Duke University 
School of Medicine; Chief Medical Officer and Senior Vice President of 
Oncology, Flatiron Health, Inc.
Anna Barker, Ph.D., Co-Director, Complex Adaptive Systems Initiative; 
President and Director, National Biomarker Development Alliance; Professor, 
School of Life Sciences, Arizona State University
Tanisha V. Carino, Ph.D., Executive Vice President, Avalere Health
John J. Castellani, President and CEO, Pharmaceutical Research and 
Manufacturers of America

Tony Coelho, Former Member, U.S. House of Representatives; 
Chairman, Partnership to Improve Patient Care

Newton F. Crenshaw, Vice President, North American Oncology 

Commercial Operations, Global Business Development and Advocacy, 
Eli Lilly and Company
William S. Dalton, Ph.D., M.D., CEO, M2Gen; Director, DeBartolo Family 
Personalized Medicine Institute, H. Lee Moffitt Cancer Center and Research 

Stephen L. Eck, M.D., Ph.D., Vice President, Global Head of Oncology 
Medical Sciences, Astellas Pharma Global Development

Shelley Fuld Nasso, M.P.P., CEO, National Coalition for Cancer Survivorship
Patricia J. Goldsmith, CEO, CancerCare
Roy S. Herbst M.D., Ph.D., Ensign Professor of Medicine, Professor 
of Pharmacology, Chief of Medical Oncology, Director of the Thoracic 
Oncology Research Program, and Associate Director for Translational 
Research, Yale Comprehensive Cancer Center and Yale School of 
Linda House, R.N., B.S.N., M.S.M., Executive Vice President, 
External Affairs, Cancer Support Community
Robert J. Hugin, Chairman and CEO, Celgene Corporation
Paul G. Kluetz, M.D., Acting Deputy Office Director, Prostate Cancer 
Scientific Liaison, Office of Hematology and Oncology Products, 
U.S. Food and Drug Administration
Michael Kolodziej, M.D., National Medical Director, Oncology Solutions, 
Office of the Chief Medical Officer, Aetna
Jennifer Malin, M.D., Ph.D., Medical Director for Oncology for Care 
Management, WellPoint, Inc.
Lee N. Newcomer, M.D., M.H.A., Senior Vice President, Oncology, 
Genetics and Women's Health, UnitedHealthcare
Richard L. Schilsky, M.D., FASCO, Chief Medical Officer, American 
Society of Clinical Oncology; Professor Emeritus, University of Chicago
Lowell Schnipper, M.D., Theodore W. and Evelyn G. Berenson Professor, 
Department of Medicine, Harvard Medical School; Chief, Hematology/Oncology, 
Beth Israel Deaconess Medical Center; Clinical Director, Beth Israel 
Deaconess Medical Center Cancer Center
Jeff A. Walker, M.B.A., Senior Executive Director for Administration, 
Comprehensive Cancer Center and James Cancer Hospital/Solove 
Research Institute, The Ohio State UniversityAACR

Register Today
Date:Thursday, October 9, 2014
Time:8:30 a.m. to 4:00 p.m.
Location:The Knight Conference Center at the Newseum, Washington, D.C.

No hay comentarios: